🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/10/2002 | 24,55 | 26,20 | 23,32 | 23,96 | -2,74% | 11,74% | 126.690 |
| 04/10/2002 | 30,09 | 30,13 | 23,92 | 24,63 | -18,36% | 20,65% | 166.311 |
| 03/10/2002 | 26,20 | 30,51 | 26,16 | 30,17 | +12,10% | 16,57% | 170.078 |
| 02/10/2002 | 26,58 | 28,00 | 24,40 | 26,91 | +0,98% | 13,52% | 138.980 |
| 01/10/2002 | 25,49 | 26,84 | 23,92 | 26,65 | +4,71% | 11,45% | 104.222 |
| 30/09/2002 | 23,21 | 26,31 | 22,65 | 25,45 | +9,68% | 15,81% | 78.974 |
| 27/09/2002 | 24,33 | 25,38 | 23,21 | 23,21 | -4,76% | 8,92% | 56.426 |
| 26/09/2002 | 25,12 | 25,27 | 23,21 | 24,37 | -0,76% | 8,20% | 66.925 |
| 25/09/2002 | 23,21 | 24,55 | 22,46 | 24,55 | +7,37% | 9,03% | 93.642 |
| 24/09/2002 | 22,72 | 23,32 | 21,52 | 22,87 | +1,83% | 7,91% | 65.349 |
| 23/09/2002 | 23,13 | 24,33 | 22,20 | 22,46 | -4,61% | 9,22% | 114.855 |
| 20/09/2002 | 24,70 | 24,70 | 21,75 | 23,54 | +6,61% | 11,97% | 273.926 |
| 19/09/2002 | 23,32 | 23,62 | 21,86 | 22,08 | -5,14% | 7,54% | 106.092 |
| 18/09/2002 | 23,54 | 24,25 | 22,46 | 23,28 | -1,27% | 7,63% | 100.802 |
| 17/09/2002 | 24,52 | 24,89 | 23,47 | 23,58 | -2,33% | 5,80% | 67.059 |
| 16/09/2002 | 24,52 | 25,27 | 24,07 | 24,14 | -3,01% | 4,89% | 86.509 |
| 13/09/2002 | 25,38 | 25,64 | 24,14 | 24,89 | -2,21% | 5,90% | 269.144 |
| 12/09/2002 | 26,50 | 26,50 | 24,40 | 25,45 | -3,82% | 7,91% | 141.812 |
| 11/09/2002 | 27,62 | 28,82 | 26,13 | 26,46 | -4,85% | 9,76% | 62.303 |
| 10/09/2002 | 26,69 | 28,18 | 26,39 | 27,81 | +5,09% | 6,73% | 112.611 |
| 09/09/2002 | 26,24 | 27,66 | 25,60 | 26,46 | +1,00% | 7,85% | 145.446 |
| 06/09/2002 | 26,80 | 27,96 | 26,05 | 26,20 | +1,30% | 7,12% | 142.720 |
| 05/09/2002 | 26,35 | 27,02 | 25,68 | 25,86 | -1,57% | 5,11% | 84.398 |
| 04/09/2002 | 26,20 | 26,95 | 25,27 | 26,28 | +0,00% | 6,43% | 102.245 |
| 03/09/2002 | 27,36 | 27,44 | 26,24 | 26,28 | -4,88% | 4,38% | 123.378 |
| 30/08/2002 | 28,26 | 28,93 | 27,36 | 27,62 | -1,86% | 5,56% | 96.501 |
| 29/08/2002 | 27,21 | 28,22 | 26,76 | 28,15 | +1,62% | 5,36% | 64.815 |
| 28/08/2002 | 27,66 | 28,22 | 27,32 | 27,70 | +1,65% | 3,25% | 123.725 |
| 27/08/2002 | 29,57 | 29,72 | 27,17 | 27,25 | -4,21% | 8,61% | 197.650 |
| 26/08/2002 | 30,32 | 30,43 | 28,00 | 28,45 | -6,17% | 8,02% | 245.713 |